Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a [...]

Biomethylation of arsenic compounds appears to cause oxidative DNA damage and to increase their carcinogenicity, according to a new study published online November 23 in the Journal of the National Cancer Institute.

The estimated 4.6 million Americans involved in the equine industry may be at risk of developing respiratory symptoms due to poor air quality in horse barns, according to a questionnaire study undertaken earlier this year by investigators at Tufts University’s Cummings School of Veterinary Medicine. The study – which polled more than 80 New England [...]

The U.S. Food and Drug Administration approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.

The global fight against swine flu is shining a spotlight on North Carolina’s long-term commitment to biomanufacturing.
Global pharmaceutical giant GlaxoSmithKline, with North American headquarters in Research Triangle Park, is one of the world’s two key manufacturers of antiviral flu treatments. GSK makes Relenza at its plant in Zebulon, about 25 miles east of its headquarters [...]